✦ LIBER ✦

Mycophenolate Mofetil and Calcineurin-Inhibitor Reduction: Recent Progress

✍ Scribed by Josep M. Grinyó; Josep M. Cruzado

Book ID: 114805301
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 79 KB
Volume: 9
Category: Article
ISSN: 1600-6135
DOI: 10.1111/j.1600-6143.2009.02812.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of calcineurin inhibitor toxic

Treatment of calcineurin inhibitor toxicity by dose reduction plus introduction of mycophenolate mofetil

✍ W McKane; C Kanganas; R Preston; T Cairns; N Hakim; A Palmer; D Taube 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Mycophenolate mofetil reduces calcineuri

Mycophenolate mofetil reduces calcineurin inhibitor–induced side effects after liver transplantation

✍ R Pfitzmann; J Klupp; J.M Langrehr; R Neuhaus; G Junge; U Settmacher; T Steinmül 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Replacement of calcineurin inhibitors by

Replacement of calcineurin inhibitors by mycophenolate mofetil: effect on hemoglobine levels

✍ B Suwelack; V Kobelt; U Hillebrand; U Gerhardt; F Matzkies; H Hohage 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Calcineurin Inhibitor Reduction Based on

Calcineurin Inhibitor Reduction Based on Maintenance Immunosuppression With Mycophenolate Mofetil in Renal Transplant Patients: POP Study

✍ L.M. Pallardó; F. Oppenheimer; L. Guirado; J. Conesa; L.J. Hortal; R. Romero; M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Mycophenolate mofetil in combination wit

Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation

✍ Georges-Philippe Pageaux; Lionel Rostaing; Yvon Calmus; Christophe Duvoux; Clair 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

The purpose of the study was to introduce mycophenolate mofetil (MMF) in liver transplant recipients with renal dysfunction to decrease calcineurin inhibitor (CNI) dosages without increasing rejection risk. In this prospective, multicenter, randomized study, chronic CNI-related renal dysfunction was

Comparative Study of Clinical Outcome in

Comparative Study of Clinical Outcome in Kidney Transplantation Between Early Steroid Withdrawal Protocol Using Basiliximab, Calcineurin Inhibitor, and Mycophenolate Mofetil and Triple Regimen Consisting of Calcineurin Inhibitor, Mycophenolate Mofetil, and Steroid

✍ S. Teraoka; S. Sato; M. Sekijima; K. Iwado; Y. Urashima; S. Kudo; K. Kai; I. Koy 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 63 KB